Deadline for proposals under PLI scheme for bulk drugs extended till March-end
The DoP had issued notice on 27th January inviting applications for vacant slots (10 APIs) under PLI scheme for bulk drug with the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
KSMs
Government imports APIs worth Rs 28,529 crores in FY2020-21
The size of the API and Intermediates market in India is estimated to be Rs 96,000 crores in FY 2019-20
Achieving Aatmanirbharta in APIs: Are we on the right track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector.…
Pharmexcil seeks Indian Ambassador in China’s help on Sichuan Airline issue
Sichuan Airlines recently suspended all its cargo flights to India for 15 days, causing major disruption to private traders'…
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials
Caution that if the situation continues, there could be a scarcity of medicines in the country
Govt likely to announce short term incentive scheme, excipient makers may get benefit
DoP officials are formulating the guidelines
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
Delay in customs clearance of China consignments may hamper pharma production: Industry
To avoid disruption in medicines production, the industry seeks immediate intervention from the government
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Finding the silver lining about coronavirus pandemic
As India Pharma Inc reels under the far-reaching impact of the coronavirus epidemic, industry experts suggest policy reforms to…